Fredericksen Discusses on Fox 5 News the U.S. Park Police’s Use of Deadly Force Following Fender Bender
January 25, 2018
Fox 5 News
Fox 5 News in Washington DC interviewed partner Scott Fredericksen about whether the U. S. Park Police’s use of deadly force was justified in the fatal shooting last year of a 25-year-old man who was involved in a high-speed chase with law enforcement following a fender bender in Fairfax County, Virginia.
Fredericksen told Fox 5 News that videos of the shoooting were “disturbing.”
“There did not appear to be any threat to the police officers and certainly not to the public,” Fredericksen said. “There was no imminent danger to the police officers. When the car stops for the third time, the police are not in jeopardy, it doesn’t seem, and the car is not trying to run them over and when it pulls away it is at a slow rate of speed away from them and looking like it is going to go into a ditch.”
Watch the interview here.
Fredericksen told Fox 5 News that videos of the shoooting were “disturbing.”
“There did not appear to be any threat to the police officers and certainly not to the public,” Fredericksen said. “There was no imminent danger to the police officers. When the car stops for the third time, the police are not in jeopardy, it doesn’t seem, and the car is not trying to run them over and when it pulls away it is at a slow rate of speed away from them and looking like it is going to go into a ditch.”
Watch the interview here.
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."